Oppenheimer Global Growth Revenue ETF
RGRO
RGRO was delisted on the 7th of March, 2017.
3 hedge funds and large institutions have $260K invested in Oppenheimer Global Growth Revenue ETF in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
1,082% more capital invested
Capital invested by funds: $22K → $260K (+$238K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAAS
First Allied Advisory Services
San Diego,
California
|
+$233K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
RGRO Hedge Fund Activity: Q4 2016 in Review
3 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Oppenheimer Global Growth Revenue ETF (RGRO) for Q4 2016, worth a combined $260K — up 1,082% from $22K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RGRO positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was First Allied Advisory Services, opening a new position worth an estimated $233K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $6K sold.
- 3 institutional investors held Oppenheimer Global Growth Revenue ETF (RGRO) as of Q4 2016, up from 2 in Q3 2016.
- Funds reported $260K of Oppenheimer Global Growth Revenue ETF stock for Q4 2016, up 1,082% quarter-over-quarter.
- 2 funds opened new Oppenheimer Global Growth Revenue ETF positions in Q4 2016 and 1 closed out, a net change of +1 holder.
- The largest Oppenheimer Global Growth Revenue ETF buyer in Q4 2016 was First Allied Advisory Services, an estimated $233K added.
- The largest Oppenheimer Global Growth Revenue ETF seller in Q4 2016 was Tower Research Capital (TRC), an estimated $6K sold.
Based on aggregated 13F filings for Q4 2016.